Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fesomersen in Total Knee Arthroplasty
NCT01713361Phase 2Completed
- Sponsor
- Ionis Pharmaceuticals
- Start
- Oct 2012
- Primary completion
- May 2014
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 5
01
Overview
A Phase 2 trial of fesomersen in venous thromboembolism (VTE), sponsored by Ionis Pharmaceuticals. Started Oct 2012; status: completed.
02
Drugs
fesomersen
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01713361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01713361.